- $207.15bn
- $252.62bn
- $36.75bn
- 96
- 42
- 94
- 92
REG - Geode Capital Mgmnt Amgen Inc. - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. - Form 8.3 - Amgen Inc.
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20221227_HORIZON THERAPEUTICS PLC_38.5 (b)_BOFAS
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20221223_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20221227_HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - BkofA Merrill Lynch Horizon Therapeutics - 20221223_HORIZON THERAPEUTICS PLC_38.5 (b)_MLPFS
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. - Form 8.3 - Amgen Inc.
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. - Form 8.3 - Amgen Inc.
AnnouncementREG - Irish Takeover Panel - Disclosure Table
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. - Form 8.3 - Amgen Inc.
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. - Form 8.3 - Amgen Inc.
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. - Form 8.3 - Amgen Inc.
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. - Form 8.3 - Amgen Inc.
AnnouncementREG - Geode Capital Mgmnt Amgen Inc. Horizon Therapeutics - Form 8.3 - Horizon Therapeutics plc
Announcement